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Background
Biventricular cardioverter-defibrillators (CRT-D) are life-saving devices that are used 
in cardiac resynchronization therapy (CRT). CRTs involve the synchronization of both 
ventricles in order to maintain ventricular contraction towards the septum. This requires 
Abstract 
Background: Using of active cardiac medical devices increases steadily. In Europe, 
there were 183 implants of ICD and 944 implants of PM, 119 of biventricular ICD and 41 
of biventricular PM, all per million inhabitants in 2014. Healthcare environments, includ-
ing radiotherapy treatment rooms, are considered challenging for these implantable 
devices. Exposure to radiation may cause the device to experience premature elective 
replacement indicator, decreased pacing amplitude or pacing inhibition, inappropri-
ate shocks or inhibition of tachyarrhythmia therapy and loss of device function. These 
impacts may be temporary or permanent. The aim of this study was to evaluate the 
influence of linear accelerator ionizing radiation dose of 10 Gy on the activity of the 
biventricular cardioverter-defibrillator in different position in radiation beam.
Methods: Two identical wireless communication devices with all three leads were 
used for the measurement. Both systems were soused into solution saline and exposed 
in different position in the beam of linear accelerator per 10 Gy fractions. In comparison 
of usually used maximum recommended dose of 2 Gy, the radiation doses used in test 
were five times higher. Using the simultaneous monitoring wireless communication 
between device and its programmer allowed watching of the devices activities, noise 
occurrence or drop of biventricular pacing on the programmer screen, observed by 
local television loop camera.
Results: At any device position in radiation beam, there were no influences of the 
device activity at dose of 10 Gy neither a significant increase of a solution saline tem-
perature in any of the measured positions of CRT-D systems in linear accelerator.
Conclusions: The results of the study indicated, that the recommendation dose for 
treating the patients with implantable devices are too conservative and the risk of 
device failure is not so high. The systems can easily withstand the dose fractions of tens 
Gy, which would allow current single-dose-procedure treatment in radiation therapy. 
Even though the process of the random alteration of device memory and electrical 
components by scatter particles not allowed to specify a safe dose during ionizing 
radiation, this study showed that the safe limit are above the today used dose fractions.
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a permanent pacing using two leads implanted in the right ventricle and in the coro-
nary veins of the left ventricle. CRTs are currently among the standard procedures used 
for the non-pharmacological treatment of severe heart failure and have been extensively 
used in recent years in the therapeutic management of patients with end-stage heart 
failure [1] to increase the ejection fraction. The evidence of the clinical benefit of CRTs 
offers randomized studies including patients with QRS > 120 ms as a marker of ventricu-
lar dyssynchrony.
The CRT-D implant rate has been steadily increasing worldwide. By conservative esti-
mates, at least one million patients in the USA have permanent artificial cardiac pace-
makers [2] and this figure could be in excess of five million patients worldwide [3–5]. 
These patients may also need to be treated using radiation therapy and any oncology 
department should expect at least several patients with these devices coming in every 
year. Radiation therapy is known to have an effect on pacemaker and implantable cardi-
overter-defibrillator function [6] via electromagnetic interference or through the effects 
of ionizing radiation [7–11]. The effects of radiation therapy on pacemakers has been 
studied in detail in the past [11–16]. Based on the studies’ results, the American Asso-
ciation of Physicists in Medicine (AAPM) presented recommendations for irradiation 
of pacemaker patients in 1994 [7] and divided the hazards into two categories—electro-
magnetic noise interference and radiation damage. The studies mentioned in the AAPM 
report encompass older pacemaker types based on an old dipole and the first genera-
tion of complementary metal oxide semiconductor (CMOS) technology. Modern pace-
makers, using newer CMOS circuitry, differ from these devices both in their sensitivity 
to radiation and in the type of malfunction observed [10]. The effect of irradiation on 
CMOS technology has also already been described in detail [8].
In the case of implanted cardiac devices, the workflow of treatment planning and 
delivery is specific for different departments. It is necessary to minimize the dose for 
devices with aid of contouring as an “organ” at risk. We usually use treatment plans with 
a minimal number of monitor units and with the shortest treatment time. Pacemaker 
functioning is checked before and after the first fraction as well as after the radiation 
course is administered (Fig. 1).
The novelty of our study lies in the unique simultaneous monitoring of the devices 
during radiation sessions. In previous studies, the devices were just inspected before and 
after the radiation session by accessing the system, without the possibility of checking 
the maintaining of the pacing [17–20].
Methods
To take measurements, two identical biventricular cardioverter-defibrillators, the Cog-
nis model P107 Boston Scientific (Natick, MA, USA) with wireless communication 
between the device and programmer, were used. Commonly-used leads were attached 
to the devices: The Fineline Sterox II model 4459 (right atrium port), the Endotak Reli-
ance SG model 0182 (right ventricle and defibrillation ports) and the Acuity Easyaccess 
model 4554 (left ventricle port). This system was placed into a plastic container contain-
ing a saline solution up to 1 cm above the device. Pacing and defibrillation impedances 
were measured and were within the manufacturers’ required limits.
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The CRT-D devices were programmed according to current clinical recommendations. 
The brady pacing mode remained DDD with a Lower Rate Limit of 70 min−1 and Rate 
Hysteresis off. The output paced the atrium and after 180 ms, it simultaneously paced 
both ventricles with a Pulse Amplitude of 2 V for the right atrium and ventricle, a Pulse 
Amplitude of 4 V for left ventricle and a Pulse Width of 0.5 ms. The LV pacing vector 
configuration was LV tip ->LV ring. Tachycardia detection zones were 160 min−1 for VT 
and 200 min−1. Shock therapy was on. All other parameters were set at nominal values 
as detailed in Table 1 and all therapies were on.
The type of programmer used was a Boston Scientific (formerly Guidant) Zoom Lati-
tude model 3120 with the ability to wirelessly communicate (ZIP™ wandless telemetry) 
with a device. During the trial, the device was interrogated and a programmer screen 
was placed in front of the camera so that the traces and markers could be watched in the 
linear accelerator controller room. During radiation exposure, the strip from program-
mer was printed at a slow speed of 10 mm/s to document and check the pacing activity 
of the device.
An Elekta Precise linear accelerator was used to provide radiation with a photon beam 
of 6 MeV, 1a 0 × 10 cm field in aperture, distance to the source of 0.80 m and a dose 
rate of 800 cGy/min. This linear accelerator is used for all solid tumors. 6 MeV energy is 
dedicated mostly for areas cranially from the diaphragm. We measured 30 cm from the 
central beam on both sides, on the central beam and in the machine room.
Results
During the study, we took seven measurements from different positions of the CRT-D 































Fig. 1 Linear accelerator measurement setup. The numbers represent the cases in the text. Horizontal pro-
jection (above), side projection (below)
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The CRT-D can with all three leads attached was placed in plastic containers filled with 
saline solution as was already described with the distance to radiation source of 0.80 m. 
The field in aperture was 10 × 10 cm in all seven cases. The temperature of the saline 
solution was measured before and after the irradiation of the system. The CRT-D mark-
ers and signals were watched using a camera focused on the programmer screen and 
also printed using an internal programmer printer. With this radiation dose, we did not 
notice any electromagnetic interference, any drop of biventricular pacing or any other 
contingencies.
Case 1
The middle of the CRT-D can was placed 30 cm from the central beam on the patient 
deck in the direction from the machine room. The radiation dose was 10 Gy. The tem-
perature of the saline solution remained unchanged at 16 °C.
Case 2
The middle of the CRT-D can was placed 30 cm from the central beam on the patient 
deck in the direction to the machine room. The radiation dose was 10 Gy. The tempera-
ture of the saline solution however increased from 16.0 °C to 17.7 °C.
Case 3
The middle of the CRT-D can was placed on the central beam on the patient deck. The 
radiation dose was 0.5 Gy. The temperature of the saline solution remained unchanged.
Case 4
The middle of the CRT-D can was placed on the central beam on the patient deck. The 
radiation dose was 2 Gy. The temperature of the saline solution however decreased from 
17.7 °C to 17.5 °C.
Table 1 Programming of CRT-D devices
Parameter CRT-D setting
Pacing mode DDD
Lower rate limit 70 bpm
Hysteresis Off
Upper rate Nominal 130 bpm
AV delay Dynamic 120–180 ms
Ventricular pacing BiV
RA, RV sense polarity bipolar
LV pace polarity bipolar LV tip -> LV ring
Rate smoothing Off
VT zone 160 bpm
First VT therapy Burst: 8 pulses at 81 %
Scan: 8 pulses with 10 ms decr.
Second VT therapy 26 J
Third-last VT therapy Maximum energy 41 J
VF zone 200 bpm
First VF therapy 26 J
Second-last VF therapy Maximum energy 41 J
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Case 5
The middle of the CRT-D can was placed on the central beam on the patient deck. The 
radiation dose was 10 Gy. The temperature of the saline solution remained unchanged.
Case 6
The middle of the CRT-D can was placed on the central beam on the patient deck. The 
radiation dose was increased 10  Gy. The temperature of the saline solution remained 
unchanged.
Case 7
The CRT-D can with the lead system was placed in the machinery room of the lin-
ear accelerator. The radiation dose was 10  Gy. The temperature of the saline solution 
remained unchanged.
Conclusions
After radiation exposure, the electrical parameters of the pacing system were checked 
with no significant differences compared to the initial values. Within the devices 
included in our measurement, there were no observed episodes of device reset, noise 
sensing, EMI or drop of biventricular pacing with irradiation up to a dose of 10 Gy. Com-
pared to the typically-used maximum recommended dose of 2 Gy, the radiation doses 
used in our test were five times higher. For the CRT-D devices used in our study, there 
are no manufacturer’s recommendations or guidelines for managing patients undergo-
ing radiotherapy. But with the knowledge that the market available cardiac implantable 
devices are made from similar components, we can generalize our results to similar 
CRT-Ds. We limited the results of this measurement to the use of a 6-MV beam with 
photons as a main component. At higher radiation levels, other effects must be taken 
into consideration.
Based on recommendations by Guidant from 2003 regarding scatter radiation and 
ICDs, ICDs may be five to ten times more sensitive to radiation damage than pace-
makers since the operating instructions are stored in random access memory that may 
be more easily damaged by scatter radiation [21]. The best way to safety proceed with 
radiation therapy for patients with an implanted cardiac device would be simultaneous 
monitoring on the programmer for devices using wireless communication between the 
implant and the programmer.
Discussion
The impact of therapeutic radiation on implanted devices is difficult to predict. Of 
course, the type of beam is an important consideration. High-energy photon beams have 
significantly more damaging effects than low-energy beams [22]. Besides this, multiple 
factors collectively determine the impact of radiation therapy on an implanted device. 
These factors include the type of implanted device, the distance from the implanted 
device to the radiation beam, the orientation of the beam to the implanted device, the 
dose rate and total dose delivered, shielding and the patient’s specific anatomy, physiol-
ogy and heath condition [23]. Due to this variability, it is not possible to specify a safe 
radiation dosage or guarantee proper device functioning following exposure to ionizing 
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radiation. The impact of ionizing radiation will also vary from one pulse generator to 
another and may range from no changes in function to a loss of pacing and defibrilla-
tion therapy. The effects of radiation exposure on an implanted device may remain unde-
tected if patient follow-up is not performed after irradiation. For this reason, clinicians 
should monitor the device continuously or perform a follow-up right after the radiation 
session.
Unfortunately, the radiation sensitivity of cardiac implants also seems to be manufac-
turer dependent. In [10], eleven devices were directly irradiated by 6 mV beams, each 
to a cumulative dose of 20  Gy. Four of the 11 devices experienced a complete loss of 
function after only 1.5 Gy of radiation. In our study, we did not see any negative influ-
ences up to several tens of Gy. Comparing our results with other older studies, the maxi-
mum destructive single dose might vary in a staggering range from 1 up to 80 Gy. It is 
theoretically possible to assess the risk of hardware circuitry damage. However, random 
alteration of device memory or electrical components by scatter particles is an issue and 
it is difficult to predict the safe level. Some devices may be susceptible to other sources 
of radiation. For example, thermal neutrons can be generated by linear accelerators and 
they can adversely affect device behavior [24, 25].
As it is not possible to absolutely shield the devices, implanted systems will always be 
somewhat susceptible to the effects of radiation, regardless of any precautions taken. 
Because most of the implanted devices now are wireless telemetry enabled, our recom-
mendation is to continuously wirelessly monitor the device during radiotherapy sessions.
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